Case File
efta-02531306DOJ Data Set 11OtherEFTA02531306
Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02531306
Pages
4
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Sent:
To:
Subject:
Jeffrey Epstein <[email protected]>
Sunday, August 15, 2010 4:41 PM
Re:
only of your innocence
On Sun, Aug 15, 20=0 at 3:47 AM, <
Jealous? R u?
wro=e:
Sent via BlackBerry from T-Mobile
<=r>
From: Jeffrey Epstein <[email protected] <mailto:jeevacation@gma=l.com»
Date: Sun, 15 Au 2010 01:30:03 -0600
To:
Subjec=: Re:
fun?
> wrote:
On Fri, Aug 13, 2010 =t 12:31 PM, Jeffrey Epstein <[email protected] <[email protected]»
I applaud your determination.
On Fri, Aug 13, 2010 at 2:28 PM, .;
wrote:
That is why I don't like any synthetic pills and I am sorry I took i=.
Sent via BlackBerry from T-Mobile
From: Jeffr=y Epstein <[email protected] <mailto:[email protected]»
Date: Fri, 13 Aug 2010 14:10:06 -0400
To:
Subject: Re:
This is exactly what i mean , it is manurafctued like any ot=er industrial chemical, without the
necesssary testing.. you need to study= you need to read , you need to look, and see. not just believe. The meratonin in
dietary supplements is generally manufactured synthetically but is chemically identical to the melatonin produced =n
EFTA_R1_01674669
EFTA02531306
the body. Supplements are required to list their source of melatonin if made directly from pl=nt or animal sources. If the
source is not given, it is assumed to be synthetic. However, neither the U.S. Food and Drug Administration (FDA) or any
other state or federal agency routinely tests supplements for quality prior to sale. Consequently, Consumerlab.com
conducted their own tests on melatonin supplements to determine if they met label claims, to make sure they
disintegrated properly and ensure they did not contain unacceptable levels of lead, a potential contaminant.
On Fri, Aug 13, 2 at 1:51 PM, wrote:
Melatonin is naturally produced in our bodies
Sent via BlackBerry=from T-Mobile
From: Jeffrey Epstein <[email protected]>
Date: Fri, 13 Aug 2010 12:55:52 -0400
=0: `
1>
Subject: Re:
melatonin is a supplement , not a drug„ IT is more dange=ous , it has not undergone
testing,
On =ri, Aug 13, 2010 at 12:46 PM,
=pan> wrote:
For example I =ook two pills of melatonin last night for better sleep and I woke
up 10am =his morning so sleepy
S000 lazy... Messed up all my day :)
Now on my way to Hamtons!!! Weee! First time this summer!
Have a go=d day Jeffrey!
Sent via BlackBerry from T-Mobile
Jeffrey Epstein <[email protected] <mailto:[email protected]»
Date: Fri, 13 Aug 2010 07:17:18 -0400
To: <1=>
Subject:
You use the internet , cell phone. email, text, wear clothe= that contain
polyester, shoes that have rubber, shop in stores with elect=ic lights, carry bags made of plastic., travel by air, and
subway.. These =hings are createdby science„ . eating an apple as many effects„ most =nknown, taking an aspirin has
been studied for years. I understand your=reluctance, and as i can see I am patient. JUst look around you , most =f the
things you do are related and have been created by people in labo=otories. not farmers.
2
EFTA_R1_01674670
EFTA02531307
T=e information contained in this communication is confidential, may be a=torney-client privileged, may
constitute inside information, and is int=nded only for the use of the addressee. It is the property of
Jeffrey Epstein
Unau=horized use, disclosure or copying of this communication or any part th=reof is strictly prohibited
and may be unlawful. If you have received t=is communication in error, please notify us immediately by
return e-mail or=by e-mail to [email protected]
<mailto:[email protected]> , and destroy this communication and all copies t=ereof,
including all attachments.
The information contain=d in this communication is confidential, may be attorney-client privileí, may
constitute inside information, and is intended only for the use of the a=dressee. It is the property of
Jeffrey Epstein
Unauthorized use, di=closure or copying of this communication or any part thereof is strictl= prohibited
and may be unlawful. If you have received this communication in error, pêse notify us immediately by
return e-mail or by e-mail to [email protected], =nd destroy this communication and all copies thereof,
including all attachments.
•♦r***
*S **
The information contain=d in this communication is confidential, may be attorney-client privileí, may
constitute inside information, and is intended only for the use of the a=dressee. It is the property of
Jeffrey Epstein
Unauthorized use, di=closure or copying of this communication or any part thereof is strictl= prohibited
and may be unlawful. If you have received this communication in error, pêse notify us immediately by
return e-mail or by e-mail to [email protected], =nd destroy this communication and all copies thereof,
3
EFTA_R1_01674671
EFTA02531308
including all attachments.
The information contain=d in this communication is confidential, may be attorney-client privileí, may
constitute inside information, and is intended only for the use of the a=dressee. It is the property of
Jeffrey Epstein
Unauthorized use, di=dosure or copying of this communication or any part thereof is strictl= prohibited
and may be unlawful. If you have received this communication in error, pêse notify us immediately by
return e-mail or by e-mail to [email protected], =nd destroy this communication and all copies thereof,
induding all attachments.
The information contain=d in this communication is confidential, may be attorney-client privileí, may
constitute inside information, and is intended only for the use of the a=dressee. It is the property of
Jeffrey Epstein
Unauthorized use, di=dosure or copying of this communication or any part thereof is strictl= prohibited
and may be unlawful. If you have received this communication in error, pease notify us immediately by
return e-mail or by e-mail to [email protected], =nd destroy this communication and all copies thereof,
including all attachments.
The information contain=d in this communication is confidential, may be attorney-client privileí, may constitute
inside information, and is intended only for the use of the a=dressee. It is the property of Jeffrey Epstein Unauthorized
use, di=closure or copying of this communication or any part thereof is strictl= prohibited and may be unlawful. If you
have received this communication in error, pêse notify us immediately by return e-mail or by e-mail to
[email protected], and destroy thi= communication and all copies thereof, including all attachments.
4
EFTA_R1_0 1674672
EFTA02531309
Technical Artifacts (9)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Domain
consumerlab.comEmail
[email protected]Email
[email protected]Email
[email protected]Email
[email protected]Phone
2531306Phone
2531307Phone
2531308Phone
2531309Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
OtherUnknown
FEDWIRE PAYMENT DEBIT ADVICE
DOJ EFTA Data Set 10 document EFTA01273102
16p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.